United States· US:0096-0721_4bac1be4-bde9-8a04-e063-6394a90a438e
Daily Facial Moisturizer
A medicinal product containing homosalate; avobenzone; octinoxate; octocrylene, registered in United States by Person and Covey.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HOMOSALATE; AVOBENZONE; OCTINOXATE; OCTOCRYLENE
- Manufacturer
- Person and Covey
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11009607211010 g in 1 TUBE (0096-0721-10)
- ndc11009607214545 g in 1 BOTTLE (0096-0721-45)
- ndc110096-0721-10
- ndc110096-0721-45
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/04394ec2-e251-4e14-9158-61cd8644c69a GET /v1/drugs/04394ec2-e251-4e14-9158-61cd8644c69a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".06; .03; .075; .015",
"substance": "HOMOSALATE; AVOBENZONE; OCTINOXATE; OCTOCRYLENE",
"productndc": "0096-0721",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/g; g/g; g/g; g/g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about homosalate; avobenzone; octinoxate; octocrylene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.